目次

Table of Contents

1. Executive Summary

2. RNA Targeting Small Molecules Therapeutics Market Characteristics

3. RNA Targeting Small Molecules Therapeutics Market Trends And Strategies

4. RNA Targeting Small Molecules Therapeutics Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global RNA Targeting Small Molecules Therapeutics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global RNA Targeting Small Molecules Therapeutics Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global RNA Targeting Small Molecules Therapeutics Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market

6. RNA Targeting Small Molecules Therapeutics Market Segmentation
6.1. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
mRNA (Messenger Ribonucleic Acid) Translation Modulators
RNA (Ribonucleic Acid) Splicing Modification
Direct RNA (Ribonucleic Acid) Targeting
Other Offerings
6.2. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Lung Fibrosis
Cancer
Neurodegenerative Diseases
Autoimmune
Inflammatory
Other Therapeutic Indications
6.3. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Drug Discovery
Oncology Research
Disease Identification
6.4. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Research Laboratories
Pharmaceutical And Biotechnology Companies
Other End-Users

7. RNA Targeting Small Molecules Therapeutics Market Regional And Country Analysis
7.1. Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market
8.1. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China RNA Targeting Small Molecules Therapeutics Market
9.1. China RNA Targeting Small Molecules Therapeutics Market Overview
9.2. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India RNA Targeting Small Molecules Therapeutics Market
10.1. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan RNA Targeting Small Molecules Therapeutics Market
11.1. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia RNA Targeting Small Molecules Therapeutics Market
12.1. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia RNA Targeting Small Molecules Therapeutics Market
13.1. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea RNA Targeting Small Molecules Therapeutics Market
14.1. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe RNA Targeting Small Molecules Therapeutics Market
15.1. Western Europe RNA Targeting Small Molecules Therapeutics Market Overview
15.2. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK RNA Targeting Small Molecules Therapeutics Market
16.1. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany RNA Targeting Small Molecules Therapeutics Market
17.1. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France RNA Targeting Small Molecules Therapeutics Market
18.1. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Italy RNA Targeting Small Molecules Therapeutics Market
19.1. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Spain RNA Targeting Small Molecules Therapeutics Market
20.1. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. Eastern Europe RNA Targeting Small Molecules Therapeutics Market
21.1. Eastern Europe RNA Targeting Small Molecules Therapeutics Market Overview
21.2. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. Russia RNA Targeting Small Molecules Therapeutics Market
22.1. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. North America RNA Targeting Small Molecules Therapeutics Market
23.1. North America RNA Targeting Small Molecules Therapeutics Market Overview
23.2. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. USA RNA Targeting Small Molecules Therapeutics Market
24.1. USA RNA Targeting Small Molecules Therapeutics Market Overview
24.2. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Canada RNA Targeting Small Molecules Therapeutics Market
25.1. Canada RNA Targeting Small Molecules Therapeutics Market Overview
25.2. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. South America RNA Targeting Small Molecules Therapeutics Market
26.1. South America RNA Targeting Small Molecules Therapeutics Market Overview
26.2. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Brazil RNA Targeting Small Molecules Therapeutics Market
27.1. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

28. Middle East RNA Targeting Small Molecules Therapeutics Market
28.1. Middle East RNA Targeting Small Molecules Therapeutics Market Overview
28.2. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

29. Africa RNA Targeting Small Molecules Therapeutics Market
29.1. Africa RNA Targeting Small Molecules Therapeutics Market Overview
29.2. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

30. RNA Targeting Small Molecules Therapeutics Market Competitive Landscape And Company Profiles
30.1. RNA Targeting Small Molecules Therapeutics Market Competitive Landscape
30.2. RNA Targeting Small Molecules Therapeutics Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Bayer AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Sanofi S.A.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. AstraZeneca plc
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Eli Lilly and Company
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. RNA Targeting Small Molecules Therapeutics Market Other Major And Innovative Companies
31.1. Amgen Inc.
31.2. Janssen Pharmaceuticals
31.3. Celgene Corporation
31.4. Vertex Pharmaceuticals
31.5. Servier laboratories
31.6. Genentech Inc.
31.7. PTC Therapeutics Inc.
31.8. Arrakis Therapeutics
31.9. Anima Biotech Inc.
31.10. Skyhawk Therapeutics Inc.
31.11. Remix Therapeutics
31.12. Abivax SA
31.13. 858 Therapeutics
31.14. Eloxx Pharmaceuticals Inc.
31.15. STORM Therapeutics Ltd.

32. Global RNA Targeting Small Molecules Therapeutics Market Competitive Benchmarking

33. Global RNA Targeting Small Molecules Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The RNA Targeting Small Molecules Therapeutics Market

35. RNA Targeting Small Molecules Therapeutics Market Future Outlook and Potential Analysis
35.1 RNA Targeting Small Molecules Therapeutics Market In 2027 - Countries Offering Most New Opportunities
35.2 RNA Targeting Small Molecules Therapeutics Market In 2027 - Segments Offering Most New Opportunities
35.3 RNA Targeting Small Molecules Therapeutics Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7: Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8: Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 47: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 48: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 49: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 50: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 51: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 52: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 53: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 54: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 55: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 56: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 57: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 58: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 59: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 60: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 61: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 62: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 63: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 64: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 65: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 66: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 67: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 68: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 69: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 70: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 71: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 72: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 73: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 74: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 75: F. Hoffmann-La Roche Ltd. Financial Performance
Table 76: Bayer AG Financial Performance
Table 77: Sanofi S.A. Financial Performance
Table 78: AstraZeneca plc Financial Performance
Table 79: Eli Lilly and Company Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7: Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8: Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 47: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 48: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 49: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 50: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 51: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 52: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 53: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 54: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 55: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 56: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 57: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 58: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 59: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 60: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 61: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 62: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 63: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 64: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 65: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 66: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 67: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 68: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 69: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 70: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 71: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 72: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 73: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 74: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 75: F. Hoffmann-La Roche Ltd. Financial Performance
Figure 76: Bayer AG Financial Performance
Figure 77: Sanofi S.A. Financial Performance
Figure 78: AstraZeneca plc Financial Performance
Figure 79: Eli Lilly and Company Financial Performance